Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Informatics Solutions
Streamline your workflow with a new solution that delivers critical disease overviews back to you quickly, easily, and efficiently with the new Pharma360.
Topic Diseases
Citeline, Biomedtracker, Pharma Consulting, Datamonitor Heal...
Catch up on any missed COVID-19 24 hour webinar sessions
Topic Cardiovascular Coronavirus
Citeline
Get the big picture trends and key takeaways with Citeline’s infographic, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity. Using pivotal data from Sitetrove, Trialtrove and Pharmaprojects, our graphic analysis covers the major industry clinical developments as only Citeline can.
Topic Clinical Trials
Citeline
Tap into expert analysis of the trends and what they mean for the future of pharma with Citeline’s latest whitepaper, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity.
Topic Clinical Trials
Scrip
Disappointment as Roche/Chugai antibody tocilizumab misses most endpoints.
Scrip
The pandemic phase will last through late 2021/early 2022, becoming a more seasonal opportunity for several years after, Pfizer management predicted during the company's second quarter call.
Medtech Insight
A new template from the US FDA explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.
Topic Coronavirus FDA Diagnostics
Meddevicetracker
Keep your finger on the pulse of digital health technologies with Meddevicetracker’s “Digital Health: Diabetes Apps and Virtual Coaching” report. An extract of this market analysis, covering smartphone apps, continuous glucose monitoring devices, and virtual diabetes coaching, is now available.
Topic Digital Health Diabetes
Medtech Insight
The American Diabetes Association held their annual meeting virtually from June 12-16, 2020. Catch up with critical event updates and the latest developments, groundbreaking research and scientific advances from the editors and analysts at Medtech Insight, who were covering the event live and reporting on the vital medtech news and science to come out of the 80th Scientific Sessions.
Topic Diabetes
Citeline, Datamonitor Healthcare
This web event has now ended. You will be able to watch all sessions on demand soon. Register your interest now to receive an update when all sessions are available to view.
Topic Coronavirus
Skipta
With the COVID-19 pandemic raging, verified HCPs are turning to Skipta more than ever to access clinically relevant information reaching beyond the crisis. Find out how other brand managers engaged these members using Skipta’s disease-specific micro-communities.
Topic Neurology Market Intelligence
Pink Sheet
Considerations for switching from in-person to remote collection of patient- and observer-reported outcomes addressed in latest update to Q&A guidance, which also discusses Part 11 compliance requirements in the context of the pandemic and electronic collection of informed consent through MyStudies app.
Topic Coronavirus Clinical Trials
Generics Bulletin
A second wave of COVID-19 infection later this year would put even greater pressure on drugs used in patients hospitalized with serious respiratory problems, a new report warns.
Topic Coronavirus Distribution
Generics Bulletin
Coronavirus-induced stockpiling and advanced prescribing of medicines has resulted in generics companies across the world registering unprecedented growth during the first quarter of 2020. However, many companies predict sales will level off again in the next quarter and beyond. And as demand fluctuates following the COVID-19 outbreak, companies have started taking precautionary measures to avoid supply-chain disruptions.
Topic Coronavirus
Generics Bulletin
In the wake of the revelation that the US has secured rights to almost all of Gilead’s remdesivir supplies through September 2020, compulsory licensing had been raised as a possible way for countries to procure versions of the COVID-19 treatment. However, Medicines for Europe has cautioned that the procedure will not be practical to apply in Europe.
Scrip
11 Aug 2020
Medtech Insight
11 Aug 2020
Scrip
11 Aug 2020
Generics Bulletin
11 Aug 2020
Scrip
11 Aug 2020
Generics Bulletin
11 Aug 2020
Pink Sheet
11 Aug 2020
Pink Sheet
11 Aug 2020
Generics Bulletin
11 Aug 2020
Scrip
11 Aug 2020
Scrip
11 Aug 2020
HBW Insight
11 Aug 2020
Medtech Insight
11 Aug 2020
Pink Sheet
11 Aug 2020
Generics Bulletin
11 Aug 2020
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date